中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2013年
4期
151-152
,共2页
先天性心脏病%肺动脉高压%评估%治疗
先天性心髒病%肺動脈高壓%評估%治療
선천성심장병%폐동맥고압%평고%치료
Congenital heart disease%Pulmonary artery hypertension%Evaluation%Treatment
肺动脉高压是先天性心脏病最常见的并发症,导致先天性心脏病手术风险明显增高,病死率达4.9%~29.0%.本文综述了近年来国内外先天性心脏病合并肺动脉高压的诊疗进展,以期为临床治疗先天性心脏病合并肺动脉高压提供参考.
肺動脈高壓是先天性心髒病最常見的併髮癥,導緻先天性心髒病手術風險明顯增高,病死率達4.9%~29.0%.本文綜述瞭近年來國內外先天性心髒病閤併肺動脈高壓的診療進展,以期為臨床治療先天性心髒病閤併肺動脈高壓提供參攷.
폐동맥고압시선천성심장병최상견적병발증,도치선천성심장병수술풍험명현증고,병사솔체4.9%~29.0%.본문종술료근년래국내외선천성심장병합병폐동맥고압적진료진전,이기위림상치료선천성심장병합병폐동맥고압제공삼고.
Pulmonary arterial hypertension is the most common complication of congenital heart disease,resulting in congenital heart disease surgery risk increased obviously,the fatality rate was up to 4.9%-29.0%. This paper reviews the congenital heart disease at home and abroad in recent years merger pulmonary hypertension medical progress,in order to for clinical treatment of congenital heart disease in pulmonary hypertension combined to provide the reference.
